Phibro Animal Health Corp. (PAHC) financials: revenue, earnings and cash flow
Fiscal 2017–2026 + TTM · from SEC filings · data as of November 13, 2026
Summary
Phibro Animal Health’s revenue went from $764M in fiscal 2017 to $1.5B in fiscal 2026, growth of about 7.9% a year.
Net income in fiscal 2026 was $100M, a net margin of 6.6%; the highest of the period.
Over the twelve months to September 30, 2026, revenue was $1.5B and net income $103M.
Free cash flow was $10M in fiscal 2026 and positive in 8 of the 10 years shown.
The diluted share count rose 2% over the period (dilution).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.5B | $1.5B | $1.3B | $1.0B | $978M | $942M | $833M | $800M | $828M | $820M | $764M |
| Gross profit | $521M | $513M | $400M | $313M | $298M | $285M | $271M | $257M | $265M | $267M | $248M |
| Operating income | $193M | $194M | $110M | $53M | $72M | $79M | $75M | $69M | $83M | $99M | $98M |
| Net income | $103M | $100M | $48M | $2M | $33M | $49M | $54M | $34M | $55M | $65M | $65M |
| EPS (diluted) | $2.51 | $2.43 | $1.19 | $0.06 | $0.81 | $1.21 | $1.34 | $0.83 | $0.00 | $0.00 | $0.00 |
| R&D | — | $25M | $24M | $29M | $24M | $21M | $18M | $14M | $12M | $10M | $9M |
| Revenue growth | — | +17.1% | +27.4% | +4.1% | +3.8% | +13.1% | +4.1% | −3.3% | +1.0% | +7.3% | +1.7% |
Cash flow
| Fiscal year | TTM | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $86M | $69M | $80M | $88M | $13M | $32M | $48M | $59M | $47M | $70M | $98M |
| Capital spending | -$64M | -$59M | -$38M | -$41M | -$52M | -$37M | -$29M | -$34M | -$30M | -$19M | -$21M |
| Free cash flow | $22M | $10M | $42M | $46M | -$38M | -$5M | $19M | $25M | $17M | $51M | $78M |
| Dividends paid | $19M | $19M | $19M | $19M | $19M | $19M | $19M | $19M | $19M | $16M | $16M |
| Buybacks | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based pay | $2M | $2M | $717000 | $475000 | — | — | $1M | $2M | $2M | $334000 | $0 |
Balance sheet
| Fiscal year | TTM | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $82M | $77M | $115M | $81M | $91M | $93M | $91M | $82M | $79M | $56M |
| Debt | — | $794M | $768M | $349M | $369M | $325M | $341M | $260M | $231M | $244M | $250M |
| Equity | — | $385M | $286M | $257M | $283M | $262M | $239M | $188M | $216M | $185M | $151M |
| Total assets | — | $1.5B | $1.4B | $982M | $971M | $932M | $841M | $784M | $727M | $672M | $623M |
| Shares (diluted) | 41M | 41M | 41M | 41M | 41M | 41M | 41M | 41M | 41M | 40M | 40M |
Margins and returns
| Fiscal year | TTM | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 33.8% | 33.8% | 30.9% | 30.8% | 30.5% | 30.3% | 32.6% | 32.1% | 32.0% | 32.6% | 32.5% |
| Operating margin | 12.5% | 12.8% | 8.5% | 5.2% | 7.3% | 8.4% | 9.0% | 8.6% | 10.1% | 12.1% | 12.8% |
| Net margin | 6.7% | 6.6% | 3.7% | 0.2% | 3.3% | 5.2% | 6.5% | 4.2% | 6.6% | 7.9% | 8.5% |
| FCF margin | 1.4% | 0.7% | 3.2% | 4.6% | -3.9% | -0.6% | 2.3% | 3.2% | 2.1% | 6.3% | 10.1% |
| ROIC | — | 12.0% | 7.4% | 7.0% | 6.7% | 9.1% | 10.6% | 9.3% | 14.2% | 17.0% | 19.6% |
| ROE | — | 25.9% | 16.9% | 0.9% | 11.5% | 18.7% | 22.8% | 17.8% | 25.3% | 35.1% | 42.8% |
Frequently asked questions
What is Phibro Animal Health’s annual revenue?
$1.5B in fiscal 2026 and $1.5B over the twelve months to September 30, 2026.
How much profit does Phibro Animal Health make?
Net income was $100M in fiscal 2026 (net margin 6.6%).
Is Phibro Animal Health’s revenue growing?
Yes: revenue rose 17.1% in fiscal 2026 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.